Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients

NCT04654689 is registered in ClinicalTrials.gov with Fundación Universidad Católica de Valencia San Vicente Mártir as lead sponsor.

NCT NCT04654689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04654689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients
Lead sponsor
Fundación Universidad Católica de Valencia San Vicente Mártir
Phase
Phase 2
Overall status
Completed
Start date
November 20, 2021
Completion date
February 4, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis